Pharmacy Times
JUNE 4, 2025
New findings show LYR-210's potential to significantly alleviate chronic rhinosinusitis symptoms, offering hope for patients with nasal inflammation and polyps.
Viseven
JUNE 4, 2025
Have you ever stopped to wonder how your communication methods are shaping patient loyalty? It’s easy to assume patients will stay if the care is good — but is that enough in today’s digital world? A 2024 survey from Bandwidth revealed that nearly half of patients would consider switching healthcare providers if their communication needs weren’t met.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 4, 2025
Redwire Corporation has secured a contract from Aspera Biomedicines to carry out space-based research on a cancer treatment.
Fierce Healthcare
JUNE 4, 2025
Medicaid plans want Congress to let managed care organizations text members, a practice currently banned, in an upcoming reconciliation bill.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JUNE 4, 2025
Saad Usmani, MD, MBA, FACP, FASCO, explores treatment duration, patient characteristics, and toxicity profiles in transplant-ineligible patients with newly diagnosed multiple myeloma.
Fierce Healthcare
JUNE 4, 2025
The leaders at state-based insurance exchanges are expressing concern about the impact that the Republican's "Big Beautiful Bill" could have on people enrolled in Affordable Care Act plans.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmTech
JUNE 4, 2025
The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain.
Pharmacy Times
JUNE 4, 2025
New research finds that adding carboplatin to paclitaxel and adjuvant chemotherapy shows no significant survival benefits in triple-negative breast cancer (TNBC).
pharmaphorum
JUNE 4, 2025
AMPLITUDE study of J&J's Akeega could extend the use of PARP inhibitors to hormone-responsive prostate cancer
Pharmacy Times
JUNE 4, 2025
Results from the NeoADAURA trial demonstrate the sustained efficacy of osimertinib in patients with epidermal growth factor receptor-mutated (EGFRm) non-small-cell lung cancer (NSCLC).
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JUNE 4, 2025
US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava as part of a broader push into Europe
Fierce Healthcare
JUNE 4, 2025
Provider plaintiffs have described the data company's business as collusive and particularly harmful to smaller practices. MultiPlan, now Claritev, said it is confident in its legal position and ready to vigorously defend" itself as the case proceeds.
pharmaphorum
JUNE 4, 2025
Can a new on-body injector version of Sanofi's Sarclisa help it claim market share from J&J's rival top-selling Darzalex in multiple myeloma
Pharmacy Times
JUNE 4, 2025
Subcutaneous immunoglobulin (SCIg) is a hopeful alternative to intravenous immunoglobulin in patients with inflammatory myositis due to a lack of adverse effects and fewer financial constraints.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JUNE 4, 2025
Faced with the looming loss of patent protection for Keytruda, MSD is reported to be interested in buying Swiss immunology player MoonLake
Pharmacy Times
JUNE 4, 2025
Establishing a strong foundation and effective networking strategies and pursuing opportunities are key.
pharmaphorum
JUNE 4, 2025
Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US
European Pharmaceutical Review
JUNE 4, 2025
The European Council is set to begin negotiations with the European Parliament about the pharma package, having agreed its position on the new rules. The proposals comprise of a regulation and directive. Once in place, the package will represent the biggest pharmaceutical reform in over twenty years. Two of its main aims is improving competitiveness of the EU pharmaceutical industry and reducing administrative burden.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Marketing Network
JUNE 4, 2025
Artificial intelligence is no longer a futuristic conceptit’s here and evolving fast. From automating clinical trials to generating marketing insights, AI in pharma jobs is transforming the healthcare industry. But with automation accelerating, a pressing question emerges: will AI replace pharma jobs or enhance them? Table of Contents The Rise of AI in Pharma Roles Most at Risk (and Why) Emerging Opportunities Through AI Strategic Adaptation for the Pharma Workforce Conclusion FAQs The Ris
Fierce Healthcare
JUNE 4, 2025
This week on "Podnosis," were examining the future of tech-enabled home care and the policy decisions that could determine whether these models become permanent fixtures in the U.S. healthcare system.
Pharmaceutical Technology
JUNE 4, 2025
The Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to potential rivals.
Pharmaceutical Commerce
JUNE 4, 2025
Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than one.
Pharmaceutical Technology
JUNE 4, 2025
Already offering the only non-invasive treatment for SMA in liquid form, Roches Evrysdi now comes as a tablet.
Pharmaceutical Commerce
JUNE 4, 2025
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.
Pharmaceutical Technology
JUNE 4, 2025
In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh in the US, ATS 2025 commentary, and more
PharmTech
JUNE 4, 2025
EMA has published recommendations to address potential radiopharmaceutical shortages.
Pharmaceutical Technology
JUNE 4, 2025
Agenus has signed $141m partnership agreements with Zydus Lifesciences, expanding patient access to BOT/BAL.
Pharmaceutical Commerce
JUNE 4, 2025
In the final part of his Pharma Commerce video interview, Scott Tillman, Logilitys senior vice president of innovation, discusses how uncertainty can help reshape the way organizations prioritize supply chain investments.
Pharmaceutical Technology
JUNE 4, 2025
The European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).
Pharma Times
JUNE 4, 2025
Treatment provides option for children with growth failure
PharmTech
JUNE 4, 2025
Jon Ellis and Simon Vanstone, PhD, go behind the headlines to explore the latest M&A activity and what tariffs and funding changes could mean for mRNA and beyond.
Pharmacy Times
JUNE 4, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
The FDA Law Blog
JUNE 4, 2025
By Mark A. Tobolowsky & Ricardo Carvajal Among other things, EO 14212 established the Make America Healthy Again (MAHA) Commission (with HHS Secretary Kennedy as its Chair) and tasked it with a tall order: submission to the President of an Assessment that tackled 10(!) complex public health issues within 100(!) days. Perhaps it was inevitable that the Commission would turn to AI for help, as seems to have been the case in light of media reports that the Assessment as originally published in
Expert insights. Personalized for you.
110 
Let's personalize your content